ReviewTherapeutic advances in neurological disorders2015

Monoclonal antibody therapies for the treatment of relapsing-remitting multiple sclerosis: differentiating mechanisms and clinical outcomes.

Jan LyckePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.